CIP2A and lung carcinoma: Immunoblot assays were conducted on 100 pairs of lung cancer tissues, revealing high CIP2A expression in 49% of the lung cancer samples (Figure 1A and Figure S1) and the numbers and percentages according to other clinical parameters are summarized in Table S2.